Suggest "Bridging" Fewer Warfarin Patients With Enoxaparin
You'll see LESS use of "bridging" with low-molecular-weight heparin (enoxaparin, etc) in warfarin patients.
Up to 1 in 6 patients are bridged with an injectable anticoagulant when warfarin is temporarily stopped before surgery or a procedure...hoping to prevent a clot or stroke.
But evidence from the new BRIDGE trial will be a game changer. It suggests that bridging does more harm than good in many patients.